Lupin launches generic hypertension drug in US after regulatory nod

Lupin unit Nanomi to acquire remaining 43.38% stake in Philippines arm for up to $39.6 million


Lupin has launched Azilsartan Medoxomil tablets in the US after securing FDA approval, becoming the exclusive first-to-file generic applicant and gaining 180 days of market exclusivity for the hypertension treatment.

2 Min Read

CNBCTV18 on Google
Lupin launches generic hypertension drug in US after regulatory nod



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *